De Maria Marchiano, Ruggero
 Distribuzione geografica
Continente #
NA - Nord America 18.974
AS - Asia 13.090
EU - Europa 11.388
SA - Sud America 3.528
AF - Africa 304
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 23
Totale 47.332
Nazione #
US - Stati Uniti d'America 18.559
SG - Singapore 5.419
PL - Polonia 3.483
CN - Cina 3.217
BR - Brasile 2.896
SE - Svezia 1.947
VN - Vietnam 1.591
IT - Italia 1.451
DE - Germania 937
FR - Francia 819
IE - Irlanda 673
ID - Indonesia 509
IN - India 473
GB - Regno Unito 456
FI - Finlandia 359
JP - Giappone 344
RU - Federazione Russa 337
TR - Turchia 307
HK - Hong Kong 287
AR - Argentina 255
BD - Bangladesh 248
AT - Austria 208
UA - Ucraina 208
CA - Canada 160
NL - Olanda 146
MX - Messico 139
IQ - Iraq 136
ZA - Sudafrica 101
EC - Ecuador 96
PK - Pakistan 68
VE - Venezuela 66
CO - Colombia 63
ES - Italia 62
SA - Arabia Saudita 59
PY - Paraguay 52
MY - Malesia 49
MA - Marocco 44
BE - Belgio 43
KR - Corea 42
CH - Svizzera 40
UZ - Uzbekistan 37
PE - Perù 31
KE - Kenya 30
JO - Giordania 29
PH - Filippine 29
IR - Iran 28
RO - Romania 28
EG - Egitto 27
CL - Cile 26
DZ - Algeria 26
AE - Emirati Arabi Uniti 25
AZ - Azerbaigian 22
UY - Uruguay 21
LT - Lituania 20
NP - Nepal 20
AU - Australia 19
KZ - Kazakistan 19
JM - Giamaica 18
BG - Bulgaria 17
CZ - Repubblica Ceca 17
OM - Oman 17
AL - Albania 16
IL - Israele 16
BO - Bolivia 15
CR - Costa Rica 15
PA - Panama 15
PT - Portogallo 15
DO - Repubblica Dominicana 14
GE - Georgia 14
TN - Tunisia 13
BY - Bielorussia 12
CI - Costa d'Avorio 12
ET - Etiopia 12
TW - Taiwan 12
HN - Honduras 11
NO - Norvegia 11
RS - Serbia 11
EU - Europa 10
LB - Libano 10
LV - Lettonia 10
BH - Bahrain 9
PS - Palestinian Territory 9
TH - Thailandia 9
TT - Trinidad e Tobago 9
BB - Barbados 8
HU - Ungheria 8
SN - Senegal 8
GA - Gabon 7
GR - Grecia 7
LK - Sri Lanka 7
LU - Lussemburgo 7
NI - Nicaragua 7
SK - Slovacchia (Repubblica Slovacca) 7
XK - ???statistics.table.value.countryCode.XK??? 7
AM - Armenia 6
BA - Bosnia-Erzegovina 6
EE - Estonia 6
AO - Angola 5
HR - Croazia 5
KH - Cambogia 5
Totale 47.241
Città #
Warsaw 3.444
Singapore 2.469
Ashburn 1.741
Chandler 1.640
Fairfield 1.488
San Jose 1.445
Redmond 768
Wilmington 731
Seattle 717
Woodbridge 695
Houston 690
Beijing 679
Dublin 672
Cambridge 508
Ho Chi Minh City 491
Nanjing 487
Jakarta 425
Lauterbourg 367
Princeton 346
Ann Arbor 336
Hanoi 324
Boston 318
Hangzhou 318
Tokyo 297
Los Angeles 295
New York 289
Helsinki 277
Hong Kong 269
Rome 264
San Mateo 249
Council Bluffs 246
Dong Ket 242
São Paulo 242
Jacksonville 212
Chicago 211
Izmir 207
Dearborn 206
Frankfurt am Main 199
Cattolica 194
Dallas 182
Nanchang 181
Vienna 177
Moscow 173
Milan 156
Munich 142
London 117
Santa Clara 109
The Dalles 99
Shenyang 97
Hyderabad 92
Rio de Janeiro 91
Phoenix 89
San Diego 88
Buffalo 87
Tianjin 80
Nuremberg 77
Bremen 75
Norwalk 75
Orem 74
Hebei 72
Belo Horizonte 70
Kunming 70
Redwood City 70
Brooklyn 64
Curitiba 62
Düsseldorf 62
Mountain View 62
Shanghai 62
Paris 57
Hefei 56
Marseille 56
Da Nang 53
Jiaxing 53
Baghdad 51
Haiphong 50
Brasília 49
Denver 48
Falkenstein 48
Guangzhou 48
Chennai 47
Atlanta 46
Changsha 45
Montreal 45
Johannesburg 43
Brussels 42
Campinas 41
Boardman 38
Porto Alegre 38
San Francisco 38
Mexico City 36
Memphis 35
Tashkent 35
Toronto 35
Goiânia 33
Kuala Selangor 33
Amsterdam 31
Biên Hòa 31
Lappeenranta 31
Quito 31
Stockholm 31
Totale 29.207
Nome #
CHK1-targeted therapy to deplete DNA replication- stressed, p53-deficient, hyperdiploid colorectal cancer stem cells 438
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes 400
Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer 388
Protein pathway activation mapping of colorectal metastatic progression reveals metastasis-specific network alterations 377
The Hippo pathway in normal development and cancer 368
Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy 349
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real- world experience 341
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 339
Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer 333
PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer 329
Two-Step Co-Immunoprecipitation (TIP) Enables Efficient and Highly Selective Isolation of Native Protein-Complexes. 312
Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer 305
Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes with Different Clinical Outcome 305
Role of gonadotropin-releasing hormone analogues in metastatic male breast cancer: results from a pooled analysis 305
Type-I-interferons in infection and cancer: Unanticipated dynamics with therapeutic implications 300
Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies 296
Conditionally reprogrammed cells (CRC) methodology does not allow the in vitro expansion of patient-derived primary and metastatic lung cancer cells. 295
(1)H NMR detects different metabolic profiles in glioblastoma stem-like cells 294
Dynamic regulation of the cancer stem cell compartment by Cripto-1 in colorectal cancer 294
Translational Research in the Era of Precision Medicine: Where We Are and Where We Will Go 294
Blocking endothelin-1-receptor/β-catenin circuit sensitizes to chemotherapy in colorectal cancer 293
Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma 292
Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance 290
miR-663 sustains NSCLC by inhibiting mitochondrial outer membrane permeabilization (MOMP) through PUMA/ BBC3 and BTG2 289
Alliance Against Cancer, the network of Italian cancer centers bridging research and care 287
GLUT 1 receptor expression and circulating levels of fasting glucose in high grade serous ovarian cancer 287
GLUT 1 receptor expression and circulating levels of fasting glucose in high grade serous ovarian cancer 284
Protein drug target activation homogeneity in the face of intra- tumor heterogeneity: implications for precision medicine 282
Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma 280
Dynamic regulation of the cancer stem cell compartment by Cripto-1 in colorectal cancer 280
A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology 278
PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer 278
Replication stress in colorectal cancer stem cells 274
miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal 273
Efficacy of chemotherapy in metastatic male breast cancer patients: a retrospective study 272
Expression of phosphorylated Hippo pathway kinases (MST1/2 and LATS1/2) in HER2-positive and triple-negative breast cancer patients treated with neoadjuvant therapy 271
The autophagic protein FYCO1 controls TNFRSF10/TRAIL receptor induced apoptosis and is inactivated by CASP8 (caspase 8) 269
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B 264
Analysis of the ATR-Chk1 and ATM-Chk2 pathways in male breast cancer revealed the prognostic significance of ATR expression 261
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 261
Association between AXL, Hippo Transducers, and Survival Outcomes in Male Breast Cancer 260
Colorectal cancer: towards new challenges and concepts of preventive healthcare 256
Analysis of the ATR-Chk1 and ATM- Chk2 pathways in male breast cancer revealed the prognostic significance of ATR expression 256
DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy 256
Gene Expression Analysis of PTEN Positive Glioblastoma Stem Cells Identifies DUB3 and Wee1 Modulation in a Cell Differentiation Model 253
DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy 248
HMG-CoAR expression in male breast cancer: Relationship with hormone receptors, Hippo transducers and survival outcomes 238
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 234
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: A real-world experience 233
DNA damage and repair biomarkers in cervical cancer patients treated with neoadjuvant chemotherapy: An exploratory analysis 225
Essential versus accessory aspects of cell death: recommendations of the NCCD 2015 223
Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant 212
A pre-existing population of ZEB2+ quiescent cells with stemness and mesenchymal features dictate chemoresistance in colorectal cancer 212
Integrin a7 Is a Functional Marker and Potential Therapeutic Target in Glioblastoma 210
A BMP7 variant inhibits tumor angiogenesis in vitro and in vivo through direct modulation of endothelial cell biology 210
Exploiting bioactive natural products of marine origin: Evaluation of the meroterpenoid metachromin V as a novel potential therapeutic drug for colorectal cancer 210
1H NMR spectroscopy of glioblastoma stem‐like cells identifies alpha‐aminoadipate as a marker of tumor aggressiveness 203
A real-time integrated framework to support clinical decision making for covid-19 patients 200
Essential versus accessory aspects of cell death: Recommendations of the NCCD 2015 191
Antisense RNA for Treating Cancer and Inhibition of Metastasis and Vectors for Antisense Sequestration 191
PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells 191
CHK1 inhibitor sensitizes resistant colorectal cancer stem cells to nortopsentin 189
Inhibitor of integrin for the treatment or prevention of tumours 186
Integrin α7 Is a Functional Marker and Potential Therapeutic Target in Glioblastoma 181
KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden 179
“Triple positive” early breast cancer: an observational multicenter retrospective analysis of outcome 173
The targeting of mre11 or rad51 sensitizes colorectal cancer stem cells to chk1 inhibition 170
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 169
Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery 169
Epigenetic silencing of Id4 identifies a glioblastoma subgroup with a better prognosis as a consequence of an inhibition of angiogenesis. 164
Two-Step Co-Immunoprecipitation (TIP) 160
Blocking the APRIL circuit enhances acute myeloid leukemia cell chemosensitivity 158
C-Met/MIR-130b axis as novel mechanism and biomarker for castration resistance state acquisition 157
Control of replication stress and mitosis in colorectal cancer stem cells through the interplay of PARP1, MRE11 and RAD51 156
HSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretome 155
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence 155
Antitumor effect of miR-197 targeting in p53 wild-type lung cancer 149
Alliance Against Cancer, the network of Italian cancer centers bridging research and care 148
Two-Step Coimmunoprecipitation (TIP) enables efficient and highly selective isolation of native protein complexes 148
Prevention of chemotherapy-induced anemia and thrombocytopenia by constant administration of stem cell factor 145
Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression 145
C-Met/miR-130b axis as novel mechanism and biomarker for castration resistance state acquisition 144
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial 144
C-Met/miR-130b axis as novel mechanism and biomarker for castration resistance state acquisition 141
The inhibition of the highly expressed mir-221 and mir-222 impairs the growth of prostate carcinoma xenografts in mice 141
"Triple positive" early breast cancer: An observational multicenter retrospective analysis of outcome 140
Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo 140
Nobiletin and xanthohumol sensitize colorectal cancer stem cells to standard chemotherapy 139
Cancer stem cell-based models of colorectal cancer reveal molecular determinants of therapy resistance 137
Integrin α7 Is a Functional Marker and Potential Therapeutic Target in Glioblastoma 137
Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo 136
1H NMR spectroscopy of glioblastoma stem-like cells identifies alpha-aminoadipate as a marker of tumor aggressiveness 134
13C-Urea breath test for the diagnosis of Helicobacter pylori infection. 133
1H NMR detects different metabolic profiles in glioblastoma stem-like cells 133
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience 133
CD147 Promotes Cell Small Extracellular Vesicles Release during Colon Cancer Stem Cells Differentiation and Triggers Cellular Changes in Recipient Cells 132
Gene expression analysis of PTEN positive glioblastoma stem cells identifies DUB3 and Wee1 modulation in a cell differentiation model 131
A BMP7 variant inhibits the tumorigenic potential of glioblastoma stem-like cells 131
Mutational status of plasma exosomal KRAS predicts outcome in patients with metastatic colorectal cancer 131
Replication stress in colorectal cancer stem cells 130
Totale 22.782
Categoria #
all - tutte 205.754
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 205.754


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021287 0 0 0 0 0 0 0 0 0 0 0 287
2021/20222.817 262 265 127 133 164 145 72 419 134 125 481 490
2022/20235.168 766 704 469 554 375 648 112 454 671 125 201 89
2023/20242.747 102 918 86 132 115 221 204 83 31 84 345 426
2024/20256.514 225 123 486 228 371 347 227 401 968 768 1.380 990
2025/202616.711 2.499 650 1.387 2.262 2.320 709 2.627 696 1.010 1.306 703 542
Totale 47.983